Skip to main content
Equibles
MEDS logo

MEDS · DataMeds AI, Inc. · Investor Relations

Track MEDS — free

Use MEDS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MEDS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.86 -0.01 (-1.06%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 17, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within twelve months from the date these unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 17, 2026
Market Cap
$2.66M
Shares
3.06M
Volume · Nov 12 155.41K Avg daily vol (3M) 6.43M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-05 DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
2026-11-03 DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
2026-11-02 DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
2026-10-26 DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
2026-10-23 DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
2026-10-22 DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
2026-10-20 DataMeds Regains Compliance With NASDAQ Listing Standards
2026-10-16 DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
2026-10-14 DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
2026-10-13 DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
2026-10-12 DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx® Assay In Gynecologic Cancers
2026-09-16 DATAMEDS, AI. ACQUIRES HELOMICS AI CANCER DIAGNOSTICS LAB AND PRECISION ONCOLOGY CRO BUSINESSES FROM AXE COMPUTE
2026-08-18 DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
2026-07-29 DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
2026-07-21 WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
2026-05-29 Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock
2026-05-21 Wellgistics Health Releases Letter to Our Shareholders
2026-05-19 Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026
2026-05-19 Wellgistics Health Reports First Quarter 2026 Financials and Provides
2026-04-17 Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
2026-03-11 Wellgistics Strengthens PharmacyChain™ with Insurance Eligibility & Benefits Verification Capabilities
2026-03-09 Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet™
2026-02-13 Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion
2026-02-09 NFL Alumni Health Partners with Wellgistics Health to Deploy Technology to Improve Health Outcomes for Former NFL Players and Rural Communities
2026-01-08 Wellgistics Health Provides 2026 Corporate Outlook

Past events

Date Event Type
2026-08-21 WGRX - Investor Presentation January 2026 Presentation
2026-05-19 Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026 Event
2025-12-19 Wellgistics Health Reminds Shareholders of December 19, 2025 Record Date for Dream Bowl 2026 Meme Coin Tokens Shareholder meeting
2025-11-20 Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025 Event

Source: https://datamedsai.com/investors/

Key facts CIK 2030763 CUSIP 949503205 13F (30d) 9 filings 9 filers Visit website Investor relations